2024 Focused Update: Guidelines on Use of Corticosteroids in Sepsis, Acute Respiratory Distress Syndrome, and Community-Acquired Pneumonia

Author:

Chaudhuri Dipayan12,Nei Andrea M.3,Rochwerg Bram12,Balk Robert A4,Asehnoune Karim5,Cadena Rhonda6,Carcillo Joseph A.7,Correa Ricardo8,Drover Katherine9,Esper Annette M.10,Gershengorn Hayley B.1112,Hammond Naomi E.1314,Jayaprakash Namita1516,Menon Kusum1718,Nazer Lama19,Pitre Tyler12,Qasim Zaffer A.20,Russell James A.21,Santos Ariel P.22,Sarwal Aarti23,Spencer-Segal Joanna24,Tilouche Nejla25,Annane Djillali262728,Pastores Stephen M.29

Affiliation:

1. Department of Medicine, McMaster University, Hamilton, ON, Canada.

2. Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.

3. Department of Pharmacy, Mayo Clinic Hospital—Rochester, Rochester, MN.

4. Department of Internal Medicine, Rush University Medical Center, Chicago, IL.

5. Department of Anesthesiology, CHU Nantes, Université de Nantes, Pôle Anesthésie-Réanimation, Service d’Anesthésie Réanimation Chirurgicale, Hôtel Dieu, Nantes, France.

6. Department of Internal Medicine, Wake Forest School of Medicine, Atrium Health, Carolinas Medical Center, Charlotte, NC.

7. Department of Critical Care Medicine, University of Pittsburgh, School of Medicine, Pittsburgh, PA.

8. Department of Endocrinology, Diabetes and Metabolism, Endocrine and Metabolism Institute, Cleveland Clinic, Cleveland, OH.

9. McMaster University, Hamilton, ON, Canada.

10. Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Emory University, Atlanta, GA.

11. Division of Pulmonary, Critical Care, and Sleep Medicine, University of Miami Miller School of Medicine; Miami, FL.

12. Division of Critical Care Medicine, Albert Einstein College of Medicine, Bronx, NY.

13. Malcolm Fisher Department of Intensive Care Medicine, Critical Care Program, The George Institute for Global Health, UNSW Sydney, Newtown, NSW, Australia.

14. Malcolm Fisher Department of Intensive Care, Royal North Shore Hospital, St Leonards, NSW, Australia.

15. Department of Emergency Medicine, Henry Ford Hospital, Detroit, MI.

16. Division of Pulmonary and Critical Care Medicine, Henry Ford Hospital, Detroit, MI.

17. Division of Pediatric Critical Care, University of Ottawa and Children’s Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada.

18. Department of Pediatrics, University of Ottawa and Children’s Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada.

19. King Hussein Cancer Center Department of Pharmacy, Amman, Jordan.

20. Department of Emergency Medicine and Critical Care Medicine, University of Pennsylvania Health System, Philadelphia, PA.

21. Division of Critical Care, Department of Medicine, Centre for Heart Lung Innovation St. Paul’s Hospital University of British Columbia, Vancouver, BC, Canada.

22. Department of Surgery, Texas Tech University Health Sciences Center, Lubbock, TX.

23. Department of Neurology [Neurocritical Care], Atrium Wake Forest School of Medicine, Winston Salem, NC.

24. Department of Internal Medicine and Michigan Neuroscience Institute, University of Michigan, Ann Arbor, MI.

25. Intensive Care Unit, Service de Réanimation Polyvalente, Hôpital de Gonesse, Gonesse, France.

26. Department of Intensive Care, Raymond Poincaré Hospital, Assistance Publique-Hôpitaux de Paris, Garches, France.

27. School of Medicine Simone Veil, University of Versailles Saint Quentin, University Paris-Saclay, Versaillles, France.

28. IHU Prometheus Fédération Hospitalo-Universitaire SEPSIS, University Paris-Saclay, INSERM, Garches, France.

29. Department of Anesthesiology and Critical Care Medicine, Critical Care Center, Memorial Sloan Kettering Cancer Center, New York, NY.

Abstract

Rationale: New evidence is available examining the use of corticosteroids in sepsis, acute respiratory distress syndrome (ARDS) and community-acquired pneumonia (CAP), warranting a focused update of the 2017 guideline on critical illness-related corticosteroid insufficiency. Objectives: To develop evidence-based recommendations for use of corticosteroids in hospitalized adults and children with sepsis, ARDS, and CAP. Panel Design: The 22-member panel included diverse representation from medicine, including adult and pediatric intensivists, pulmonologists, endocrinologists, nurses, pharmacists, and clinician-methodologists with expertise in developing evidence-based Clinical Practice Guidelines. We followed Society of Critical Care Medicine conflict of interest policies in all phases of the guideline development, including task force selection and voting. Methods: After development of five focused Population, Intervention, Control, and Outcomes (PICO) questions, we conducted systematic reviews to identify the best available evidence addressing each question. We evaluated the certainty of evidence using the Grading of Recommendations Assessment, Development, and Evaluation approach and formulated recommendations using the evidence-to-decision framework. Results: In response to the five PICOs, the panel issued four recommendations addressing the use of corticosteroids in patients with sepsis, ARDS, and CAP. These included a conditional recommendation to administer corticosteroids for patients with septic shock and critically ill patients with ARDS and a strong recommendation for use in hospitalized patients with severe CAP. The panel also recommended against high dose/short duration administration of corticosteroids for septic shock. In response to the final PICO regarding type of corticosteroid molecule in ARDS, the panel was unable to provide specific recommendations addressing corticosteroid molecule, dose, and duration of therapy, based on currently available evidence. Conclusions: The panel provided updated recommendations based on current evidence to inform clinicians, patients, and other stakeholders on the use of corticosteroids for sepsis, ARDS, and CAP.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3